<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04669756</url>
  </required_header>
  <id_info>
    <org_study_id>Schäfer_Endo_Ovariopexie</org_study_id>
    <nct_id>NCT04669756</nct_id>
  </id_info>
  <brief_title>Ovariopexy for Adhesion Prevention After Laparoscopic Removal of Endometriosis of the Pelvic Side Wall or the Ovary</brief_title>
  <official_title>Ovariopexy for Adhesion Prevention After Laparoscopic Removal of Endometriosis of the Pelvic Side Wall or the Ovary</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Muenster</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Muenster</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      prospective randomized Trial comparing ovariopexy over 2, 4 or 6 days vs Placebo after&#xD;
      surgery because of endometriosis of the pelvic side wall or the ovary or both&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2018</start_date>
  <completion_date type="Actual">January 31, 2021</completion_date>
  <primary_completion_date type="Actual">January 8, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>prevalence of postoperative ovarian adhesions</measure>
    <time_frame>3 months after operation</time_frame>
    <description>prevalence of postoperative ovarian adhesions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>daily during postoperative hospitalisation and at follow up visit after 3 months</time_frame>
    <description>postoperative pain (NRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AMH</measure>
    <time_frame>at follow up visit after 3 months</time_frame>
    <description>AMH level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative infectious complications</measure>
    <time_frame>up to 3 months after operation</time_frame>
    <description>postoperative infectious complications</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">409</enrollment>
  <condition>Endometriosis</condition>
  <condition>Adhesion</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ovariopexy for 2 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ovariopexy for 4 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ovariopexy for 6 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>D</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo Operation for 2 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ovariopexy</intervention_name>
    <description>if endometriosis was removed from the pelvic side wall or the ovary or both leading to an open wound adjacent to the ovary, ovariopexy was performed on both sides using a transabdominal-transovarian suture being tied extracorporeally on the patients Skin leading to uplifting of the ovary to the abdominal wall</description>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>B</arm_group_label>
    <arm_group_label>C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>placebo operation</intervention_name>
    <description>in arm D sutures are transabdominal only</description>
    <arm_group_label>D</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  premenopausal&#xD;
&#xD;
          -  wants to participate&#xD;
&#xD;
          -  removal of endometriosis of the pelvic side wall or ovary&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  postmenopausal&#xD;
&#xD;
          -  cannot give informed consent&#xD;
&#xD;
          -  no endometriosis during Operation&#xD;
&#xD;
          -  no Opening of pelvic side wall or ovary during the Operation&#xD;
&#xD;
          -  pregnant&#xD;
&#xD;
          -  breast feeding&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sebastian D Schaefer, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Muenster, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Muenster</name>
      <address>
        <city>Münster</city>
        <state>NRW</state>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>December 4, 2020</study_first_submitted>
  <study_first_submitted_qc>December 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>April 26, 2021</last_update_submitted>
  <last_update_submitted_qc>April 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Muenster</investigator_affiliation>
    <investigator_full_name>Dr. med. Sebastian Daniel Schäfer</investigator_full_name>
    <investigator_title>Head of Gynecology</investigator_title>
  </responsible_party>
  <keyword>endometriosis</keyword>
  <keyword>ovariopexy</keyword>
  <keyword>adhesion prevention</keyword>
  <keyword>laparoscopy</keyword>
  <keyword>complications</keyword>
  <keyword>AMH</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
    <mesh_term>Tissue Adhesions</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>data can be shared upon reasonable request and according to regulations</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

